Chemours (CC) Misses Q4 EPS by 5c
Tweet
Share
E-mail
Get Alerts CC Hot Sheet
Join SI Premium – FREE
Chemours (NYSE: CC) reported Q4 EPS of $0.03, $0.05 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.36 billion.
For earnings history and earnings-related data on Chemours (CC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
